| Epidemiology and management of liver metastases from colorectal cancer S Manfredi, C Lepage, C Hatem, O Coatmeur, J Faivre, AM Bouvier Annals of surgery 244 (2), 254-259, 2006 | 1548 | 2006 |
| Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population S Manfredi, AM Bouvier, C Lepage, C Hatem, V Dancourt, J Faivre Journal of British Surgery 93 (9), 1115-1122, 2006 | 374 | 2006 |
| Continuing rapid increase in esophageal adenocarcinoma in England and Wales C Lepage, B Rachet, V Jooste, J Faivre, MP Coleman Official journal of the American College of Gastroenterology| ACG 103 (11 …, 2008 | 336 | 2008 |
| Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial J Taieb, J Tabernero, E Mini, F Subtil, G Folprecht, JL Van Laethem, ... The Lancet Oncology 15 (8), 862-873, 2014 | 305 | 2014 |
| Incidence and management of malignant digestive endocrine tumours in a well defined French population C Lepage, AM Bouvier, JM Phelip, C Hatem, C Vernet, J Faivre Gut 53 (4), 549-553, 2004 | 186 | 2004 |
| Incidence and management of primary malignant small bowel cancers: a well-defined French population study C Lepage, AM Bouvier, S Manfredi, V Dancourt, J Faivre Official journal of the American College of Gastroenterology| ACG 101 (12 …, 2006 | 181 | 2006 |
| Prognostic effect of BRAF and KRAS mutations in patients with stage III colon cancer treated with leucovorin, fluorouracil, and oxaliplatin with or without cetuximab: a post … J Taieb, A Zaanan, K Le Malicot, C Julie, H Blons, L Mineur, J Bennouna, ... JAMA oncology 2 (5), 643-653, 2016 | 170 | 2016 |
| Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5 C Lepage, R Capocaccia, M Hackl, V Lemmens, E Molina, ... European Journal of Cancer 51 (15), 2169-2178, 2015 | 158 | 2015 |
| Survival from malignant digestive endocrine tumors in England and Wales: a population-based study C Lepage, B Rachet, MP Coleman Gastroenterology 132 (3), 899-904, 2007 | 151 | 2007 |
| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 141 | 2020 |
| Quality of life after mastectomy with or without immediate breast reconstruction J Dauplat, F Kwiatkowski, P Rouanet, E Delay, K Clough, JL Verhaeghe, ... Journal of British Surgery 104 (9), 1197-1206, 2017 | 140 | 2017 |
| Transcatheter arterial embolization of splenic artery aneurysms and pseudoaneurysms: short-and long-term results R Loffroy, B Guiu, JP Cercueil, C Lepage, N Cheynel, E Steinmetz, ... Annals of vascular surgery 22 (5), 618-626, 2008 | 140 | 2008 |
| Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study P Quere, O Facy, S Manfredi, V Jooste, J Faivre, C Lepage, AM Bouvier Diseases of the Colon & Rectum 58 (8), 743-752, 2015 | 128 | 2015 |
| Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset H Blons, JF Emile, K Le Malicot, C Julié, A Zaanan, J Tabernero, E Mini, ... Annals of oncology 25 (12), 2378-2385, 2014 | 128 | 2014 |
| Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms V Dancourt, C Lejeune, C Lepage, MC Gailliard, B Meny, J Faivre European Journal of Cancer 44 (15), 2254-2258, 2008 | 123 | 2008 |
| Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study C Allemani, B Rachet, HK Weir, LC Richardson, C Lepage, J Faivre, ... BMJ open 3 (9), e003055, 2013 | 122 | 2013 |
| Trends in frequency and management of obstructing colorectal cancers in a well-defined population N Cheynel, M Cortet, C Lepage, L Benoit, J Faivre, AM Bouvier Diseases of the colon & rectum 50 (10), 1568-1575, 2007 | 122 | 2007 |
| The balance between cytotoxic T-cell lymphocytes and immune checkpoint expression in the prognosis of colon tumors L Marisa, M Svrcek, A Collura, E Becht, P Cervera, K Wanherdrick, ... JNCI: Journal of the National Cancer Institute 110 (1), 68-77, 2018 | 120 | 2018 |
| Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab A Dohan, B Gallix, B Guiu, K Le Malicot, C Reinhold, P Soyer, ... Gut 69 (3), 531-539, 2020 | 118 | 2020 |
| Epidemiology and prognosis of synchronous colorectal cancers M Latournerie, V Jooste, V Cottet, C Lepage, J Faivre, AM Bouvier Journal of British Surgery 95 (12), 1528-1533, 2008 | 117 | 2008 |
julien Taiebprofessor of medecine Hopital Europeen Georges Pompidou, Université de Paris (Paris-DescartesVerified email at egp.aphp.fr
